Why insider trading matters?

If management teams do not own any relevant stakes in the companies they guide, they may not be focused on creating wealth for shareholders to the same degree, compared to those that see their personal wealth increase when share prices rise.

- Klaus Gugler, Economist
Syneos Health, Inc. (SYNH)
Sector: Healthcare; Industry: Diagnostics & Research

Syneos Health, Inc. operates as an integrated biopharmaceutical solutions company in North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates through two segments, Clinical Solutions and Commercial Solutions. The Clinical Solutions segment offers various clinical development services spanning Phase I to Phase IV, including full-service global studies, as well as clinical monitoring, investigator recruitment, patient recruitment, data management, and study startup to assist customers with drug development process. The Commercial Solutions segment provides commercialization services, including medication adherence, communications solutions, and consulting services. Syneos Health, Inc. has a strategic agreement with Daiichi Sankyo, Inc. for the development of Daiichi Sankyo'S Adc oncology pipeline.

SYNH Symbol Info by TradingView

Trade Date Insider Title Buy/Sell #Shares Price Value Option
2022-07-21 Brooks Michael Lee Chief Operating Officer Sell 1,502 $76.00 $114,152 No
2022-07-20 Olefson Jonathan General Counsel & Corp Secty Sell 2,215 $75.00 $166,125 No
2022-07-19 Brooks Michael Lee Chief Operating Officer Sell 1,502 $74.00 $111,148 No
2022-07-18 Meggs Jason M. Chief Financial Officer Sell 7,500 $72.81 $546,075 No
2022-07-08 Kralowetz Donna Hildebrand EVP, Chief Accounting Officer Sell 1,149 $73.16 $84,061 No
2021-12-30 Brooks Michael Lee nan Sell 93 $103.00 $9,579 No
2021-12-23 Olefson Jonathan General Counsel & Corp Secty Sell 1,889 $100.95 $190,695 No
2021-12-22 Brooks Michael Lee nan Sell 93 $99.00 $9,207 No
2021-12-20 Harty Linda S Director Sell 4,122 $97.02 $399,916 No
2021-08-03 Macdonald Alistair Chief Executive Officer Sell 40,263 $88.19 $3,550,697 Yes
2021-06-07 Maldonado John L. Director Sell 6,307,489 $81.20 $512,168,107 No
2021-06-07 Allen Tom Director Sell 6,307,489 $81.20 $512,168,107 No
2021-06-07 ADVENT INTERNATIONAL CORP/MA 10%-Owner Sell 6,307,489 $81.20 $512,168,107 No
2021-06-07 ADVENT INTERNATIONAL CORP/MA 10%-Owner Sell 6,307,489 $81.20 $512,168,107 No
2021-06-07 THOMAS H. LEE ADVISORS, LLC Director Sell 5,044,187 $81.20 $409,587,984 No
2021-06-01 Macdonald Alistair Chief Executive Officer Sell 4,889 $88.20 $431,210 Yes
2021-05-12 THOMAS H. LEE ADVISORS, LLC Director Sell 379,878 $81.04 $30,785,313 No
2021-05-12 THOMAS H. LEE ADVISORS, LLC Director Sell 379,878 $81.04 $30,785,313 No
2021-05-12 THOMAS H. LEE ADVISORS, LLC Director Sell 379,878 $81.04 $30,785,313 No
2021-05-14 Maldonado John L. Director Sell 448,942 $81.04 $36,382,260 No
2021-05-14 Allen Tom Director Sell 448,942 $81.04 $36,382,260 No
2021-05-14 ADVENT INTERNATIONAL CORP/MA 10%-Owner Sell 448,942 $81.04 $36,382,260 No
2021-05-14 ADVENT INTERNATIONAL CORP/MA 10%-Owner Sell 448,942 $81.04 $36,382,260 No
2021-05-14 ADVENT INTERNATIONAL CORP/MA 10%-Owner Sell 448,942 $81.04 $36,382,260 No
2021-05-14 ADVENT INTERNATIONAL CORP/MA 10%-Owner Sell 448,942 $81.04 $36,382,260 No
2021-05-14 ADVENT INTERNATIONAL CORP/MA 10%-Owner Sell 448,942 $81.04 $36,382,260 No
2021-05-06 Maldonado John L. Director Sell 4,008,318 $81.04 $324,834,091 No
2021-05-06 ADVENT INTERNATIONAL CORP/MA 10%-Owner Sell 4,008,318 $81.04 $324,834,091 No
2021-05-06 ADVENT INTERNATIONAL CORP/MA 10%-Owner Sell 4,008,318 $81.04 $324,834,091 No
2021-05-06 ADVENT INTERNATIONAL CORP/MA 10%-Owner Sell 4,008,318 $81.04 $324,834,091 No

Insider Smart

Axsome Therapeutics, Inc (AXSM) - AXSM shows the power of an #allgreen stock, no insider selling, great management great company, if you follow the insiders last year and pick up around $25, the 52 week high is $100+.

Insider Smart

CEDAR FAIR L.P. (FUN) - Another crash victim, Cedar Fair L.P. took a deep dive from $54 to $13, insiders were confidence and eagerly jumped in around $27. With insiders on your side, this would be an easy add and hold to get your cost under $20. Stock is about to breach $40 in the coming weeks.